首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Evaluation of the measurement uncertainty in screening immunoassays in blood establishments: Computation of diagnostic accuracy models
【24h】

Evaluation of the measurement uncertainty in screening immunoassays in blood establishments: Computation of diagnostic accuracy models

机译:血液企业筛选免疫测定测量不确定性的评价:诊断精度模型的计算

获取原文
获取原文并翻译 | 示例
           

摘要

The European Union regulation for blood establishments does not require the evaluation of measurement uncertainty in virology screening tests, which is required by ISO 15189 guideline following GUM principles. GUM modular approaches have been discussed by medical laboratory researchers but no consensus has been achieved regarding practical application. Meanwhile, the application of empirical approaches fulfilling GUM principles has gained support. Blood establishments' screening tests accredited by ISO 15189 need to select an appropriate model even GUM models are intended uniquely for quantitative examination procedures. Alternative (to GUM) models focused on probability have been proposed in medical laboratories' diagnostic tests. This article reviews, discusses and proposes models for diagnostic accuracy in blood establishments' screening tests. The output of these models is an alternative to VIM's measurement uncertainty concept. Example applications are provided for an anti-HCV test where calculations were performed using a commercial spreadsheet. The results show that these models satisfy ISO 15189 principles and that the estimation of clinical sensitivity, clinical specificity, binary results agreement and area under the ROC curve are alternatives to the measurement uncertainty concept. (C) 2014 Published by Elsevier Ltd.
机译:欧盟血液企业的监管不需要评估病毒学筛查试验中的测量不确定性,这是在口香糖原则之后的ISO 15189指南所必需的。医学实验室研究人员已经讨论了胶片模块化方法,但在实际应用方面没有达成共识。同时,实现胶质原则的实证方法的应用已经获得了支持。 ISO 15189认证的血液企业的筛选试验需要选择合适的模型甚至胶模型,以唯一用于定量检查程序。在医学实验室的诊断测试中提出了专注于概率的替代(至胶)模型。本文审查,讨论并提出了血液企业筛选试验中诊断准确性的模型。这些模型的输出是Vim的测量不确定性概念的替代方案。用于使用商业电子表格进行计算的抗HCV测试的示例应用程序。结果表明,这些型号满足了ISO 15189原则,临床敏感性,临床特异性,二元成果协调和ROC曲线下的面积的估计是测量不确定性概念的替代品。 (c)2014年由elestvier有限公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号